Archives of Pediatric Infectious Diseases

Published by: Kowsar

Pyrazinamide in Treatment of Infection With Bacillus Calmette–Guerin; Does It Work?

Fariba Shirvani 1 and Maryam Rajabnejad 1 , *
Authors Information
1 Pediatric Infections Research Center, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Pediatric Infectious Diseases: April 2015, 3 (2); e59845
  • Published Online: April 15, 2015
  • Article Type: Letter
  • Received: December 22, 2014
  • Accepted: January 12, 2015
  • DOI: 10.5812/pedinfect.26312

To Cite: Shirvani F, Rajabnejad M. Pyrazinamide in Treatment of Infection With Bacillus Calmette–Guerin; Does It Work?, Arch Pediatr Infect Dis. 2015 ; 3(2):e59845. doi: 10.5812/pedinfect.26312.

Copyright © 2015, Pediartric Infections Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
  • 1. Global Tuberculosis Control. 2011;
  • 2. Pedraza-Sanchez S, Herrera-Barrios MT, Aldana-Vergara R, Neumann-Ordonez M, Gonzalez-Hernandez Y, Sada-Diaz E, et al. Bacille Calmette-Guerin infection and disease with fatal outcome associated with a point mutation in the interleukin-12/interleukin-23 receptor beta-1 chain in two Mexican families. Int J Infect Dis. 2010; 14-60[DOI][PubMed]
  • 3. Ritz N, Tebruegge M, Connell TG, Sievers A, Robins-Browne R, Curtis N. Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics. Antimicrob Agents Chemother. 2009; 53(1): 316-8[DOI][PubMed]
  • 4. Fahimzad SA, Ghasemi M, Shiva F, Ghadiri K, Navidinia M, Karimi A. Susceptibility Pattern of Bacille Calmette-Guerin Strains Against Pyrazinamide and Other Major Anti-Mycobacterial Drugs. Arch Pediatr. 2015; 3(1)[DOI]
  • 5. Fahimi F, Tabarsi P, Kobarfard F, Bozorg BD, Goodarzi A, Dastan F, et al. Isoniazid, rifampicin and pyrazinamide plasma concentrations 2 and 6 h post dose in patients with pulmonary tuberculosis. Int J Tuberc Lung Dis. 2013; 17(12): 1602-6[DOI][PubMed]
  • 6. de Jong BC, Onipede A, Pym AS, Gagneux S, Aga RS, DeRiemer K, et al. Does resistance to pyrazinamide accurately indicate the presence of Mycobacterium bovis? J Clin Microbiol. 2005; 43(7): 3530-2[DOI][PubMed]
  • 7. Pyrazinamide. 2014;
  • 8. Roy V, Tekur U, Chopra K. Pharmacokinetics of pyrazinamide in children suffering from pulmonary tuberculosis Int J Tuberc Lung Dis. 1999; 3(2)
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments